Reactions Weekly

November 2019, Volume 1781, Issue 1, pp 23–23 | Cite as

Afatinib/amrubicin

Liver dysfunction and lack of efficacy: case report

Case report

First Online: 30 November 2019

• 10 Downloads

This is a preview of subscription content, log in to check access.

Reference

1. Murano C, et al. Osimertinib as treatment for egfr exon 20 insertion-positive lung adenocarcinoma. EXCLI Journal 18: 893-898, Jan 2019. Available from: URL: http://doi.org/10.17179/excli2019-1786 - Japan

Copyright information

© Springer International Publishing AG 2019